Adamax 10mg (10 vials/kit): Advanced Adamantyl-Derivatized Nootropic Peptide for Neuroplasticity Research

Adamax is an advanced synthetic derivative of Semax (an adrenocorticotropic hormone fragment $\text{ACTH}_{4-10}$ analog) featuring dual N-terminal acetylation and C-terminal adamantyl esterification ($\text{N-Acetyl Semax Adamantane}$). Engineered to overcome the rapid enzymatic degradation and limited lipid permeability of native neuropeptides, the addition of the lipophilic adamantane cage structure dramatically increases lipophilicity and blood-brain barrier ($\text{BBB}$) penetration. In central nervous system ($\text{CNS}$) and neurobiological research models, Adamax acts as a high-potency neurotrophic modulator that upregulates brain-derived neurotrophic factor ($\text{BDNF}$) and nerve growth factor ($\text{NGF}$) while enhancing dopaminergic and serotonergic neurotransmission. Sourcing Adamax 10mg (10 vials/kit) provides neuroscientists, cognitive pharmacologists, and cellular biologists with an analytical reagent optimized to investigate synaptic plasticity, long-term potentiation ($\text{LTP}$), and neuroprotective repair cascades in vitro and in vivo.

At the molecular level, native Semax ($\text{Met-Glu-His-Phe-Pro-Gly-Pro}$) exhibits a short biological half-life due to rapid cleavage by serum aminopeptidases and carboxypeptidases. The structural modifications in Adamax resolve these pharmacokinetic limitations: N-terminal acetylation prevents aminopeptidase degradation, while the bulky C-terminal adamantyl moiety sterically blocks carboxypeptidase cleavage and facilitates direct cell membrane translocation. Upon crossing the blood-brain barrier, Adamax activates tropomyosin receptor kinase B ($\text{TrkB}$) signaling pathways, driving intracellular cascades that increase neurotrophin expression:

In preclinical models of cerebral ischemia, neuroinflammation, and cognitive exhaustion, Adamax preserves mitochondrial membrane potential in hippocampal neurons and downregulates pro-inflammatory cytokine expression ($\text{IL-1}\beta$, $\text{TNF-}\alpha$).

The Adamax 10mg (10 vials/kit) product configuration supplies a total yield of 100mg active peptide material (10mg per vial) distributed across ten individual USP Type I borosilicate glass vials. Freeze-dried under sterile vacuum conditions, each vial contains a uniform, highly stable lyophilized powder cake. This multi-vial format allows laboratory personnel to reconstitute single working units as needed while preserving remaining kit stock under deep-freeze conditions.

Adamantyl Synergy, Neurotrophic Cascade, and Technical Specifications

The scientific value of Adamax 10mg (10 vials/kit) stems from its enhanced BBB permeability, extended metabolic stability, and multi-pathway neuroprotective signaling dynamics:

• Enhanced BBB Permeability: Lipophilic adamantyl cage structure facilitates rapid passive diffusion across vascular endothelial membranes into central CNS compartments.

• BDNF & NGF Neurotrophic Upregulation: Significantly elevates hippocampal and cortical expression of brain-derived neurotrophic factor ($\text{BDNF}$) and nerve growth factor ($\text{NGF}$), promoting dendritic spine density and synaptogenesis.

• Dopaminergic System Modulation: Potentiates central dopamine release and upregulates $D_1$ and $D_2$ receptor sensitivity, supporting research on motor control, focus, and reward pathways.

• Protective Anti-Hypoxic Activity: Mitigates oxidative stress, lipid peroxidation, and glutamate excitotoxicity in neuronal cultures subjected to ischemic or hypoxic conditions.

• Ultra-High Chemical Purity ($\ge$99.0%): Manufactured via automated Solid-Phase Peptide Synthesis ($\text{SPPS}$) and purified using preparative High-Performance Liquid Chromatography ($\text{HPLC}$) to ensure complete removal of truncation sequences and unreacted adamantyl precursors.

Reconstitution Guidelines, Laboratory Storage Standards, and Quality Protocols

Achieving reproducible, publication-grade results when working with Adamax 10mg (10 vials/kit) requires strict adherence to standardized laboratory preparation and climate-controlled storage protocols.

Perform all reconstitution procedures inside a certified Class II Biosafety Cabinet:

1. Temperature Balancing: Allow the frozen Adamax vial to adjust to ambient room temperature prior to solvent introduction to eliminate moisture condensation inside the glass container.

2. Septum Sanitization: Remove the protective plastic flip-cap and thoroughly wipe the synthetic rubber stopper with a fresh 70% isopropyl alcohol pad. Allow the surface to dry completely.

3. Slow Diluent Addition: Using a sterile syringe equipped with a fine-gauge needle, draw the required volume of Bacteriostatic Water (0.9% benzyl alcohol), Sterile Normal Saline (0.9% NaCl), or Deionized Water. Direct the liquid stream against the inner glass wall so it trickles slowly over the lyophilized cake.

4. Gentle Hydration: Allow the diluent to fully hydrate the powder cake for 2 minutes. Gently roll the vial between your palms or swirl in smooth circular motions until clear. Never vortex or shake violently, as high-shear agitation can disrupt peptide tertiary structures and induce protein foaming.

5. Micro-Aliquot Strategy: For multi-week testing protocols, divide reconstituted liquid into sterile, single-use microcentrifuge tubes under aseptic conditions to prevent atmospheric oxidation and eliminate repeated freeze-thaw cycles.

Batch Quality Documentation & Traceability: Every production lot of Adamax 10mg (10 vials/kit) undergoes third-party analytical testing. High-Performance Liquid Chromatography (HPLC) chromatograms confirm component purity exceeding 99.0%, while Electrospray Ionization Mass Spectrometry (ESI-MS) confirms precise theoretical molecular mass and adamantyl attachment. Each shipment includes a batch-specific Certificate of Analysis (COA) documenting chemical purity, residual solvent analysis, heavy metal screens, and bacterial endotoxin levels (<0.05 EU/mg) to satisfy institutional compliance requirements.

Strict Regulatory & Research Compliance Statement: Adamax 10mg (10 vials/kit) is produced, packaged, and distributed exclusively for in vitro laboratory research, academic experimentation, chemical synthesis, and preclinical research. Adamax 10mg (10 vials/kit) is strictly not intended, formulated, or approved for human or animal consumption, therapeutic medical treatment, clinical diagnostic work, or cosmetic applications. All handling must be conducted by certified research personnel operating within equipped laboratory facilities in compliance with OSHA workplace safety regulations and institutional biosafety protocols.